DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors

Cancer Genetics and Cytogenetics

Volumn 179, Issue 2, 2007, Pages 140-145

  Losi Guembarovski, Roberta ^a,b   Kuasne, Hellen ^a   Guembarovski, Alda L ^a   Rainho, Cláudia A ^c   Cólus, Ilce M S ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR BETA; STRATIFIN; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; AUTOPSY; CANCER CELL; CARCINOMA; CDH1 GENE; CHILD; CHOROID PLEXUS TUMOR; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE FREQUENCY; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROEPITHELIUM; PAPILLOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RARB GENE; RARE DISEASE; RETROSPECTIVE STUDY; SFN GENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

AGED; CADHERINS; CARCINOMA; CHILD; CHILD, PRESCHOOL; CHOROID PLEXUS; CHOROID PLEXUS NEOPLASMS; DNA METHYLATION; EXONUCLEASES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMA; RECEPTORS, RETINOIC ACID; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 36148976793     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.05.029     Document Type: Article

References (35)

1. Brada M., and Thomas D.G.T. Tumors of the brain and spinal cord in adults. In: Peckham M.J., Pinedo H.M., and Veronesi U. (Eds). Oxford textbook of oncology (1995), Oxford University Press, Oxford 2085
2. Van Dyke T.A. Tumors of the choroid plexus. In: Levine A.J., and Schmidek H.H. (Eds). Molecular genetics of nervous system tumors (1993), Wiley-Liss, New York 287-301
3. Rickert C.H., Wiestler O.D., and Paulus W. Chromosomal imbalances in choroid plexus tumors. Am J Pathol 160 (2002) 1105-1113
4. Grill J., Avet-Loiseau H., Lellouch-Tubiana A., Sévenet N., Terrier-Lacombe M.J., Vénuat A.M., Doz F., Sainte-Rose C., Kalifa C., and Vassal G. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet Cytogenet 136 (2002) 121-125
5. Zakrzewska M., Wojcik I., Zakrzewski K., Polis L., Grajkowska W., Roszkowski M., Augelli B.J., Liberski P.P., and Rieske P. Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas. Cancer Genet Cytogenet 156 (2005) 179-182
6. Herman J.G. Epigenetic changes in cancer and preneoplasia. Cold Spring Harb Symp Quant Biol 70 (2005) 329-333
7. Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer 3 (2003) 253-266
8. Paluszczak J., and Baer-Dubowska W. Epigenetic diagnostics of cancer: the application of DNA methylation markers. J Appl Genet 47 (2006) 365-375
9. Lodygin D., and Hermeking H. Epigenetic silencing of 14-3-3σ in cancer. Semin Cancer Biol 16 (2006) 214-224
10. Hirohashi S., and Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 94 (2003) 575-581
11. Figarella-Branger D., Lepidi H., Poncet C., Gambarelli D., Bianco N., Rougon G., and Pellissier J.F. Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors. Acta Neuropathol (Berl) 89 (1995) 248-257
12. Boston P.F., Jackson P., Kynoch P.A.M., and Thompson R.J. Purification properties and immunohistochemical localisation of human brain 14-3-3 protein. J Neurochem 38 (1982) 1466-1474
13. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., and Vogelstein B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol Cell 1 (1997) 3-11
14. Ferguson A.T., Evron E., Umbricht C.B., Pandita T.K., Chan T.A., Hermeking H., Marks J.R., Lambers A.R., Futreal P.A., Stampfer M.R., and Sukumar S. High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 97 (2000) 6049-6054
15. Cao W.D., Zhang X., Zhang J.N., Yang Z.J., Zhen H.N., Cheng G., Li B., and Gao D. Immunocytochemical detection of 14-3-3 in primary nervous system tumors. J Neurooncol 77 (2006) 125-130
16. Soprano D.R., Qin P., and Soprano K.J. Retinoic acid receptors and cancers. Annu Rev Nutr 24 (2004) 201-224
17. Ruberte E., Friederich V., Chambon P., and Morriss-Kay G. Retinoic acid receptors and cellular retinoid binding proteins: III. Their differential transcript distribution during mouse nervous system development. Development 118 (1993) 267-282
18. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and genetics of tumors of the nervous system. 2nd ed. World Health Organization Classification of Tumours (2000), IARC Press, Lyon
19. Isola J., DeVries S., Chu L., Ghazvini S., and Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145 (1994) 1301-1308
20. Paulin R., Grigg G.W., Davey M.W., and Piper A.A. Urea improves efficiency of bisulphite-mediated sequencing of 5′-methylcytosine in genomic DNA. Nucleic Acids Res 26 (1998) 5009-5010
21. Corn P.G., Heath E.I., Heitmiller R., Fogt F., Forastiere A.A., Herman J.G., and Wu T. Frequent hypermethylation of the 5′ CpG island of E-cadherin in esophageal adenocarcinoma. Clin Cancer Res 7 (2001) 2765-2769
22. Evron E., Dooley W.C., Umbricht C.B., Rosenthal D., Sacchi N., Gabrielson E., Soito A.B., Hung D.T., Ljung B., Davidson N.E., and Sukumar S. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 357 (2001) 1335-1336
23. Sanguinetti C.J., Dias Neto E., and Simpson A.J.G. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17 (1994) 914-921
24. Michalowski M.B., de Fraipont F., Michelland S., Entz-Werle N., Grill J., Pasquier B., Favrot M.C., and Plantaz D. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 166 (2006) 74-81
25. Corn P.G., Smith B.D., Ruckdeschel E.S., Douglas D., Baylin S.B., and Herman J.G. E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia. Clin Cancer Res 6 (2000) 4243-4248
26. Toyooka S., Toyooka K.O., Harada K., Miyajima K., Makarla P., Sathyanarayana U.G., Yin J., Sato F., Shivapurkar N., Meltzer S.J., and Gazdar A.F. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62 (2002) 3382-3386
27. Chan A.O., Broaddus R.R., Houlihan P.S., Issa J., Hamilton S.R., and Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 160 (2002) 1823-1830
28. Jass J.R., Young J., and Leggett B.A. Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol 17 (2002) 17-26
29. Azarschab P., Porschen R., Gregor M., Blin N., and Holzmann K. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromosomes Cancer 35 (2002) 121-126
30. Nass S.J., Herman J.G., Gabrielson E., Iversen P.W., Parl F.F., Davidson N.E., and Graff J.R. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 60 (2000) 4346-4348
31. Bornman D.M., Mathew S., Alsruhe J., Herman J.G., and Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159 (2001) 831-835
32. Umbricht C.B., Evron E., Gabrielson E., Ferguson A., Marks J., and Sukumar S. Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer. Oncogene 20 (2001) 3348-3353
33. Bhatia K., Siraj A.K., Hussain A., Bu R., and Gutierrez M.I. The tumor suppressor gene 14-3-3 σ is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol Biomarkers Prev 12 (2003) 165-169
34. Banelli B., Gelvi I., Di Vinci A., Scaruffi P., Casciano I., Allemanni G., Bonassi S., Tonini G.P., and Romani M. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene 24 (2005) 5619-5628
35. Klein O., Grignon Y., Civit T., Auque J., and Marchal J.C. Methylation status of RARβ; gene promoter in low and high grade cerebral glioma: comparison with normal tissue; Immuno-histochemical study of nuclear RARβ expression in low and high grade cerebral glioma cells: comparison with normal cells; 48 tumors. [In French]. Neurochirurgie 51 (2005) 147-154